rs45539432
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_032409.3(PINK1):c.1366C>T(p.Gln456Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,614,232 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032409.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PINK1 | NM_032409.3 | c.1366C>T | p.Gln456Ter | stop_gained | 7/8 | ENST00000321556.5 | NP_115785.1 | |
PINK1-AS | NR_046507.1 | n.3085G>A | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PINK1 | ENST00000321556.5 | c.1366C>T | p.Gln456Ter | stop_gained | 7/8 | 1 | NM_032409.3 | ENSP00000364204 | P1 | |
PINK1-AS | ENST00000451424.1 | n.3085G>A | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
PINK1 | ENST00000400490.2 | n.459C>T | non_coding_transcript_exon_variant | 3/4 | 2 | |||||
PINK1 | ENST00000492302.1 | n.2816C>T | non_coding_transcript_exon_variant | 4/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251246Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135842
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461868Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727234
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74500
ClinVar
Submissions by phenotype
Autosomal recessive early-onset Parkinson disease 6 Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2415). This premature translational stop signal has been observed in individual(s) with early-onset Parkinson disease (PMID: 16769864, 18685134, 28502045). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs45539432, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Gln456*) in the PINK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PINK1 are known to be pathogenic (PMID: 15087508, 15349870). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 16, 2008 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2024 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21508222, 25226871, 21700325, 19500570, 20508036, 21408140, 22043288, 25525159, 16009891, 17219214, 18685134, 23251494, 29331938, 33845304, 31589614, 32557143, 33045815, 31345219, 28716427, 37750340, 37256495, 16769864) - |
PINK1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 08, 2024 | The PINK1 c.1366C>T variant is predicted to result in premature protein termination (p.Gln456*). This variant has been reported in the homozygous state and to a lesser extent in the heterozygous state in several individuals with early-onset Parkinson disease (Bonifati et al. 2005. PubMed ID: 16009891; Grünewald et al. 2009. PubMed ID: 19500570; Siuda et al. 2014. PubMed ID: 25226871; Lesage et al. 2020. PubMed ID: 33045815; Milanowski et al. 2021. PubMed ID: 33845304). In vitro functional studies in patient fibroblast cells demonstrate that expression of this variant resulted in a significant decrease in cellular ATP levels compared to controls but no observable difference in ATP synthesis or effect on the enzyme activity of the respiratory chain (Grünewald et al. 2009. PubMed ID: 19500570). This variant is reported in 0.0078% of alleles in individuals of European (non-Finnish) descent in gnomAD. Nonsense variants in PINK1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at